1. Home
  2. LDOS vs NTRA Comparison

LDOS vs NTRA Comparison

Compare LDOS & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LDOS
  • NTRA
  • Stock Information
  • Founded
  • LDOS 1969
  • NTRA 2003
  • Country
  • LDOS United States
  • NTRA United States
  • Employees
  • LDOS N/A
  • NTRA N/A
  • Industry
  • LDOS EDP Services
  • NTRA Medical Specialities
  • Sector
  • LDOS Technology
  • NTRA Health Care
  • Exchange
  • LDOS Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • LDOS 21.0B
  • NTRA 21.7B
  • IPO Year
  • LDOS 2006
  • NTRA 2015
  • Fundamental
  • Price
  • LDOS $177.63
  • NTRA $163.02
  • Analyst Decision
  • LDOS Buy
  • NTRA Strong Buy
  • Analyst Count
  • LDOS 13
  • NTRA 16
  • Target Price
  • LDOS $187.50
  • NTRA $193.50
  • AVG Volume (30 Days)
  • LDOS 933.1K
  • NTRA 1.7M
  • Earning Date
  • LDOS 08-05-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • LDOS 0.90%
  • NTRA N/A
  • EPS Growth
  • LDOS 233.94
  • NTRA N/A
  • EPS
  • LDOS 10.58
  • NTRA N/A
  • Revenue
  • LDOS $17,053,000,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • LDOS $5.10
  • NTRA $19.98
  • Revenue Next Year
  • LDOS $3.33
  • NTRA $16.16
  • P/E Ratio
  • LDOS $16.78
  • NTRA N/A
  • Revenue Growth
  • LDOS 6.53
  • NTRA 44.38
  • 52 Week Low
  • LDOS $123.62
  • NTRA $110.57
  • 52 Week High
  • LDOS $202.90
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • LDOS 68.63
  • NTRA 65.28
  • Support Level
  • LDOS $175.66
  • NTRA $152.62
  • Resistance Level
  • LDOS $182.88
  • NTRA $161.92
  • Average True Range (ATR)
  • LDOS 3.77
  • NTRA 6.11
  • MACD
  • LDOS 1.03
  • NTRA 3.42
  • Stochastic Oscillator
  • LDOS 80.24
  • NTRA 93.78

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: